Stefan Nilsson - Insider Transactions
Insider Type
individual
Companies
2
Average
11,326,898
Total Txns
15
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2016 | 0 | 1 | -1 | 0.00 | 232,934.88 | -232,934.88 |
| 2022 | 6 | 0 | 6 | 158,292,355.20 | 0.00 | 158,292,355.20 |
| 2023 | 3 | 0 | 3 | 24,154.34 | 0.00 | 24,154.34 |
| 2024 | 5 | 0 | 5 | 27,133.10 | 0.00 | 27,133.10 |
| Total: | 14 | 1 | 10 | 158,343,642.64 | 232,934.88 | 158,110,707.76 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Lipigon Pharmaceuticals AB SE0015382072 |
0.19 SEK |
95,164 Bought |
18,500 SEK |
06/12/2024 | 03/12/2024 |
| Lipigon Pharmaceuticals AB SE0015382072 |
0.17 SEK |
342,315 Bought |
57,733 SEK |
06/12/2024 | 02/12/2024 |
| Lipigon Pharmaceuticals AB SE0015382072 |
0.24 SEK |
313,425 Bought |
75,104 SEK |
12/09/2024 | 10/09/2024 |
| Lipigon Pharmaceuticals AB SE0015382072 |
0.29 SEK |
136,056 Bought |
38,950 SEK |
18/06/2024 | 17/06/2024 |
| Lipigon Pharmaceuticals AB SE0015382072 |
0.34 SEK |
300,852 Bought |
101,293 SEK |
21/04/2024 | 19/04/2024 |
| Lipigon Pharmaceuticals AB SE0015382072 |
0.43 SEK |
311,804 Bought |
134,771 SEK |
20/12/2023 | 20/12/2023 |
| Lipigon Pharmaceuticals AB SE0015382072 |
0.37 SEK |
182,432 Bought |
67,865 SEK |
20/07/2023 | 20/07/2023 |
| Lipigon Pharmaceuticals AB SE0015382072 |
1.09 SEK |
40,825 Bought |
44,499 SEK |
23/01/2023 | 20/01/2023 |
| Lipigon Pharmaceuticals AB SE0015382072 |
44,499.60 SEK |
37,083 Bought |
1,650,178,667 SEK |
28/11/2022 | 25/11/2022 |
| Lipigon Pharmaceuticals AB SE0015382072 |
1.91 SEK |
35,590 Bought |
67,977 SEK |
31/08/2022 | 31/08/2022 |